Thursday, May 01, 2008 4:46:42 PM
The company earned $26.2 million, or 76 cents a share, compared with $26.5 million, or 77 cents a share, in the year-ago period.
Excluding several one-time items, the company earned 72 cents a share in the latest quarter.
Revenue rose 5 percent to $270.7 million for the quarter. Currency translation contributed 6.3 percent of sales growth.
Excluding currency translation effects, pharmaceutical systems segment sales grew at 0.7 percent, and tech group segment sales declined by 5.9 percent. Both segments' sales were affected by expected sales declines, the company added.
Analysts on average were expecting earnings of 69 cents a share, before items, on revenue $262 million, according to Reuters Estimates.
The company also raised its 2008 forecast to reflect revised exchange rates.
The company now expects to earn $2.40 to $2.50 a share before items, on revenue of $ 1.08 billion. Analysts average forecast is earnings of $2.46 a share on revenue of $1.06 billion.
West Pharmaceutical shares closed at $46.91 Wednesday on Nasdaq. (Reporting by Jennifer Robin Raj in Bangalore; Editing by Amitha Rajan)
© Thomson Reuters 2008 All rights reserved
Recent WST News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/10/2024 05:35:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/09/2024 07:38:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2024 07:39:43 PM
- West to Participate in Upcoming Investor Conference • PR Newswire (US) • 04/30/2024 10:00:00 AM
- West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend • PR Newswire (US) • 04/25/2024 10:00:00 AM
- West to Host First-Quarter 2024 Conference Call • PR Newswire (US) • 04/11/2024 10:00:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/01/2024 09:24:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 06:07:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:35:17 PM
- West to Participate in Upcoming Investor Conferences • PR Newswire (US) • 02/28/2024 09:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2024 09:23:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 04:37:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:50:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:47:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:40:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:29:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:22:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:16:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:13:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 11:01:17 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/20/2024 09:44:29 PM
- West Announces Second-Quarter 2024 Dividend • PR Newswire (US) • 02/20/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 12:51:00 PM
- West Announces Fourth-Quarter and Full-Year 2023 Results • PR Newswire (US) • 02/15/2024 11:00:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONG • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM